Nordea Investment Management AB Increases Position in DENTSPLY SIRONA Inc. $XRAY

Nordea Investment Management AB grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 71.0% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 428,015 shares of the medical instruments supplier’s stock after buying an additional 177,750 shares during the period. Nordea Investment Management AB owned 0.21% of DENTSPLY SIRONA worth $6,853,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Allianz Asset Management GmbH raised its holdings in shares of DENTSPLY SIRONA by 56.3% in the second quarter. Allianz Asset Management GmbH now owns 828,670 shares of the medical instruments supplier’s stock valued at $13,159,000 after buying an additional 298,413 shares during the last quarter. NorthRock Partners LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth about $207,000. Envestnet Portfolio Solutions Inc. raised its holdings in DENTSPLY SIRONA by 36.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock worth $246,000 after purchasing an additional 4,165 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in DENTSPLY SIRONA by 159.5% during the second quarter. Sequoia Financial Advisors LLC now owns 28,408 shares of the medical instruments supplier’s stock worth $451,000 after purchasing an additional 17,461 shares in the last quarter. Finally, CWM LLC raised its holdings in DENTSPLY SIRONA by 139.9% during the second quarter. CWM LLC now owns 228,097 shares of the medical instruments supplier’s stock worth $3,622,000 after purchasing an additional 133,010 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Up 3.4%

Shares of XRAY opened at $12.93 on Tuesday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a 50 day simple moving average of $13.39 and a 200-day simple moving average of $14.52. DENTSPLY SIRONA Inc. has a 1-year low of $11.69 and a 1-year high of $24.86. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of -2.73, a price-to-earnings-growth ratio of 0.78 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. DENTSPLY SIRONA’s payout ratio is currently -13.50%.

Analysts Set New Price Targets

Several research analysts recently issued reports on XRAY shares. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Finally, Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.